Altered cardiac annexin mRNA and protein levels in the left ventricle of patients with end-stage heart failure
- PMID: 9515022
- DOI: 10.1006/jmcc.1997.0608
Altered cardiac annexin mRNA and protein levels in the left ventricle of patients with end-stage heart failure
Abstract
Annexins are a unique family of membrane-associated, Ca2+ and phospholipid-binding proteins found in various tissues. Among the 12 isoforms, Annexin II, V and VI exist in heart tissue in the highest amounts. Annexin VI has been shown to affect intracellular Ca2+ cycling and contractility in isolated cardiomyocytes. Annexin V is present in both cardiomyocytes and non-myocyte cell types in the heart and may play a role in the regulation of cellular ion fluxes, organization and secretion, while the cardiac effects of annexin II are unclear. To identify changes in annexin II, V and VI isoforms that might occur in human heart failure, we measured mRNA and protein levels of these three annexins in transplanted left ventricular tissue of 12 patients with end-stage congestive heart failure due to coronary artery disease (CAD, n=6) or idiopathic dilated cardiomyopathy (DCM, n=6) who underwent cardiac transplantation. Normal heart tissue (C, n=6) was used as a control. Northern blot analyses showed a significant decrease (61%) in annexin VI mRNA levels in heart failure patients compared with controls (1.08+/-0.16 v 2.79+/-0.20 A.U.C. unit, determined by laser densitometry, mean+/-s.e.). In contrast, we found a 67% increase (2. 32+/-0.27 v 3.88+/-0.29) in annexin II mRNA levels and a two-fold increase (1.00+/-0.24 v 2.21+/-0.29) in annexin V mRNA levels in cardiomyopathic hearts as compared to normal hearts. Western blot analyses demonstrated a corresponding decrease (46.1%) in annexin VI protein levels in the heart failure group as compared to controls (2. 63+/-0.22 v 4.88+/-0.52), while annexin II protein levels showed a significant 40.7% increase in patients with heart failure compared to those in normal hearts (5.08+/-0.67 v 3.61+/-0.32). Annexin V protein levels were also significantly increased (45%) in heart failure patients compared with normal (2.14+/-0.19 v 1.48+/-0.11). No difference in either annexins II, V or VI mRNA and protein levels were found between CAD and DCM patients. We conclude that human end-stage heart failure is associated with a down regulation of annexin VI and up regulation of annexin II and V proteins. Coordinate changes were observed in steady-state mRNA levels. These results suggest that these annexin isoforms may contribute to the regulation of intracellular Ca2+ homeostasis in the cardiomyopathic heart.
Copyright 1998 Academic Press Limited
Similar articles
-
Expression and localization of the annexins II, V, and VI in myocardium from patients with end-stage heart failure.Lab Invest. 2000 Feb;80(2):123-33. doi: 10.1038/labinvest.3780016. Lab Invest. 2000. PMID: 10701682
-
Annexins, calcium-dependent phospholipid binding proteins in irreducible heart failure.Rev Med Chir Soc Med Nat Iasi. 2013 Jul-Sep;117(3):648-53. Rev Med Chir Soc Med Nat Iasi. 2013. PMID: 24502030
-
Annexins and Ca2+ handling in the heart.Cardiovasc Res. 2005 Mar 1;65(4):793-802. doi: 10.1016/j.cardiores.2004.11.010. Cardiovasc Res. 2005. PMID: 15721859 Review.
-
Presence and comparison of Ca2+ transport activity of annexins I, II, V, and VI in large unilamellar vesicles.Biochem Biophys Res Commun. 1997 Aug 28;237(3):499-503. doi: 10.1006/bbrc.1997.7177. Biochem Biophys Res Commun. 1997. PMID: 9299392
-
Annexin VI regulation of cardiac function.Biochem Biophys Res Commun. 2004 Oct 1;322(4):1171-7. doi: 10.1016/j.bbrc.2004.07.127. Biochem Biophys Res Commun. 2004. PMID: 15336965 Review.
Cited by
-
Reduced annexin A6 expression promotes the degradation of activated epidermal growth factor receptor and sensitizes invasive breast cancer cells to EGFR-targeted tyrosine kinase inhibitors.Mol Cancer. 2013 Dec 19;12(1):167. doi: 10.1186/1476-4598-12-167. Mol Cancer. 2013. PMID: 24354805 Free PMC article.
-
Comprehensive mendelian randomization reveals atrial fibrillation-breast cancer relationship and explores common druggable targets.Front Pharmacol. 2024 Aug 7;15:1435545. doi: 10.3389/fphar.2024.1435545. eCollection 2024. Front Pharmacol. 2024. PMID: 39170695 Free PMC article.
-
Differential protein expression and basal lamina remodeling in human heart failure.Proteomics Clin Appl. 2016 May;10(5):585-96. doi: 10.1002/prca.201500099. Epub 2016 Jan 25. Proteomics Clin Appl. 2016. PMID: 26756417 Free PMC article.
-
Balancing functions of annexin A6 maintain equilibrium between hypertrophy and apoptosis in cardiomyocytes.Cell Death Dis. 2015 Sep 3;6(9):e1873. doi: 10.1038/cddis.2015.231. Cell Death Dis. 2015. PMID: 26335715 Free PMC article.
-
THAP5 is a human cardiac-specific inhibitor of cell cycle that is cleaved by the proapoptotic Omi/HtrA2 protease during cell death.Am J Physiol Heart Circ Physiol. 2009 Aug;297(2):H643-53. doi: 10.1152/ajpheart.00234.2009. Epub 2009 Jun 5. Am J Physiol Heart Circ Physiol. 2009. PMID: 19502560 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous